Review
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2008; 14(22): 3464-3470
Published online Jun 14, 2008. doi: 10.3748/wjg.14.3464
Table 2 Summary of clinical liver cell transplantation procedures for liver-based inborn errors of metabolism
IndicationnPatient ageCell amount (% liver cell mass)Follow-upReferences
Familial hypercho-lesterolemia57-41 yrPartial reduction of LDL (3/5 patients)69
Donor hepatocytes detected by ISH at 4 mo
CN disease type I110 yr7.5 × 109 (5%)Decrease of bilirubin levels up to 11 mo14
Detection of UGT1A1 enzyme activity and of glucurono-conjugates in bile
19 yr7.5 × 109 (5%)50%-65% reduction of bilirubin up to 3 mo34
Donor hepatocytes not detected by short tandem repeat analysis at 40 d
218 mo/3 yrND50%/30% reduction of serum bilirubin over 7 mo/ND follow-up33
Donor hepatocytes detected in one case by short tandem repeat analysis at 8 mo
Infantile refsum disease14 yr2 × 109Donor Y-chromosomes detected by PCR at 7 d20
Inherited coagulation factor VII deficiency23 mo/2 yr1.1 × 109/2.2 × 109 (4%/3%)Decrease in the factor VII requirements19
PFIC 22ND0.3 × 109No improvement33
Glycogen storage disease type Ia147 yr2 × 109(1%)Fasting tolerance: up to 7 h18
Increase of glycemia
Improvement of diet
G6Pase activity detected
Urea cycle disease1 (OTC)5 yr1 × 109Improvement of ammonia levels70
Detection of enzyme activity
1 (OTC)0 d10.5 × 109Transient metabolic improvement between 20 and 31 d of life71
1 (OTC)1 d1.9 × 109Improvement of ammonia levels72
Increased urea synthesis
1 (OTC)14 mo2.4 × 109 (6%)Improvement of psychomotor development and of ammonia levels16
Urea neo-synthesis
1 (ASL)3.5 yr4.7 × 109 (9%)Improvement of psychomotor development and of ammonia levels17
Donor hepatocytes detected by FISH at 12 mo and by enzyme activity at 8 mo